Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance

Metabolism. 2000 Feb;49(2):151-4. doi: 10.1016/s0026-0495(00)91065-5.


This study evaluated the ability of insulin to regulate free fatty acid (FFA) concentrations in healthy nondiabetic subjects selected to be either insulin-resistant or -sensitive on the basis of insulin-mediated glucose disposal by muscle. Comparisons of steady-state plasma glucose (SSPG), insulin (SSPI), and FFA concentrations were made at the end of 3 infusion periods: (1) under basal insulin conditions (approximately 10 microU/mL), (2) in response to isoproterenol-induced stimulation of lipolysis at the same basal insulin concentration, and (3) following inhibition of isoproterenol-induced lipolysis by a 2-fold increase in the insulin concentration. The results showed that steady-state FFA concentrations were significantly higher under basal conditions (360 +/- 73 v 158 +/- 36 microEq/L, P = .02), in response to isoproterenol-induced lipolysis (809 +/- 92 v433 +/- 65 microEq/L, P = .005), and following insulin inhibition of isoproterenol-induced lipolysis (309 +/- 65 v 159 +/- 37 microEq/L, P = .06). These differences were found despite the fact that SSPG concentrations were also higher in insulin-resistant individuals during all 3 infusion periods. These results demonstrate that the ability of insulin to regulate plasma FFA concentrations is impaired in healthy subjects with muscle insulin resistance, indicating that insulin-resistant individuals share defects in the ability of insulin to stimulate muscle glucose disposal and to inhibit adipose tissue lipolysis.

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenergic beta-Agonists / pharmacology
  • Blood Pressure / drug effects
  • Fatty Acids, Nonesterified / blood*
  • Female
  • Humans
  • Insulin / blood
  • Insulin / physiology*
  • Insulin Resistance / physiology*
  • Isoproterenol / pharmacology
  • Male
  • Middle Aged
  • Muscle, Skeletal / metabolism*


  • Adrenergic beta-Agonists
  • Fatty Acids, Nonesterified
  • Insulin
  • Isoproterenol